Related references
Note: Only part of the references are listed.Diagnostic stability in substance-induced psychosis
Lucia Inchausti et al.
REVISTA DE PSIQUIATRIA Y SALUD MENTAL (2022)
Will Legalization and Commercialization of Cannabis Use Increase the Incidence and Prevalence of Psychosis?
Robin M. Murray et al.
JAMA PSYCHIATRY (2020)
Brain NMDA Receptors in Schizophrenia and Depression
Albert Adell
BIOMOLECULES (2020)
Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia A Systematic Review and Meta-analysis
Katherine Beck et al.
JAMA NETWORK OPEN (2020)
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis
Guy Hindley et al.
LANCET PSYCHIATRY (2020)
A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis Substance Use and Misuse
Alexandra Voce et al.
SUBSTANCE USE & MISUSE (2019)
Longitudinal Alterations in Prefrontal Resting Brain Connectivity in Non-Treatment-Seeking Young Adults With Cannabis Use Disorder
Jazmin Camchong et al.
FRONTIERS IN PSYCHIATRY (2019)
Is there a discrete negative symptom syndrome in people who use methamphetamine?
Alexandra Voce et al.
COMPREHENSIVE PSYCHIATRY (2019)
Risks of psychosis in methamphetamine users: cross-sectional study in Thailand
Warot Lamyai et al.
BMJ OPEN (2019)
Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
Robert A. McCutcheon et al.
TRENDS IN NEUROSCIENCES (2019)
The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
M. Kokkinou et al.
MOLECULAR PSYCHIATRY (2018)
Psychiatry & the psychedelic drugs. Past, present & future
James J. H. Rucker et al.
NEUROPHARMACOLOGY (2018)
Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine
Lee E. Dunlap et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Substance-Induced Psychosis: An Indicator of Development of Primary Psychosis?
Subroto Ghose
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis
Marie Stefanie Kejser Starzer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
A systematic review of risk factors for methamphetamine-associated psychosis
Shalini Arunogiri et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2018)
Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review
P. Molero et al.
CNS DRUGS (2018)
Relationship between the duration of methamphetamine use and psychotic symptoms: A two-year prospective cohort study
Jun Ma et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
Profile of psychiatric symptoms in methamphetamine users in China: Greater risk of psychiatric symptoms with a longer duration of use
Jun Ma et al.
PSYCHIATRY RESEARCH (2018)
The prevalence of substance-induced psychotic disorder in methamphetamine misusers: A meta-analysis
Tania Lecomte et al.
PSYCHIATRY RESEARCH (2018)
The acute effects of cannabis on human executive function
Priscilla P. Oomen et al.
BEHAVIOURAL PHARMACOLOGY (2018)
Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review
Lorna Wilson et al.
SCHIZOPHRENIA RESEARCH (2018)
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
Celia J. A. Morgan et al.
TRANSLATIONAL PSYCHIATRY (2018)
A Research of Methamphetamine Induced Psychosis in 1,430 Individuals With Methamphetamine Use Disorder: Clinical Features and Possible Risk Factors
Hong Gan et al.
FRONTIERS IN PSYCHIATRY (2018)
A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology
Travis A. Wearne et al.
FRONTIERS IN PSYCHIATRY (2018)
Persistent Psychosis due to Single Dose of Ecstasy
Sanya Virani et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2018)
Epidemiological Characteristics and Risk Factors of Methamphetamine-Associated Psychotic Symptoms
Meng-Fan Su et al.
FRONTIERS IN PSYCHIATRY (2018)
Factors affecting the occurrence of psychotic symptoms in chronic methamphetamine users
Lili Nie et al.
JOURNAL OF ADDICTIVE DISEASES (2018)
The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids
C. Michael White
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review
Matthew D. Cooper et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2017)
Cannabis-associated psychosis: Neural substrate and clinical impact
R. M. Murray et al.
NEUROPHARMACOLOGY (2017)
Modern Clinical Research on LSD
Matthias E. Liechti
NEUROPSYCHOPHARMACOLOGY (2017)
Drug Abuse and Psychosis: New Insights into Drug- induced Psychosis
Suji Ham et al.
EXPERIMENTAL NEUROBIOLOGY (2017)
Cannabis induced psychosis and subsequent psychiatric disorders
Dharav Shah et al.
ASIAN JOURNAL OF PSYCHIATRY (2017)
Primary psychosis with comorbid drug abuse and drug-induced psychosis: Diagnostic and clinical evolution at follow up
M. C. Mauri et al.
ASIAN JOURNAL OF PSYCHIATRY (2017)
Synthetic cannabinoids: the hidden side of Spice drugs
Nicholas Pintori et al.
BEHAVIOURAL PHARMACOLOGY (2017)
Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies
Rafael G. dos Santos et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2017)
A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment
Robert J. Tait et al.
CLINICAL TOXICOLOGY (2016)
Psychosis associated with acute recreational drug toxicity: a European case series
Odd Martin Vallersnes et al.
BMC PSYCHIATRY (2016)
Keep off the grass? Cannabis, cognition and addiction
H. Valerie Curran et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Classic hallucinogens in the treatment of addictions
Michael P. Bogenschutz et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users
Rebecca McKetin et al.
PSYCHIATRY RESEARCH (2016)
Catatonia Secondary to Synthetic Cannabinoid Use in Two Patients With No Previous Psychosis
Madiha Khan et al.
AMERICAN JOURNAL ON ADDICTIONS (2016)
Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population
Julia M. Lappin et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2016)
Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia
Anna Hoeflich et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Ketamine Users Have High Rates of Psychosis and/or Depression
Hua Jun Liang et al.
JOURNAL OF ADDICTIONS NURSING (2015)
GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC
Rajiv Radhakrishnan et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Novel psychoactive substances of interest for psychiatry
Fabrizio Schifano et al.
WORLD PSYCHIATRY (2015)
Associations between psychotic symptoms and substance use in young offenders
Louisa Degenhardt et al.
DRUG AND ALCOHOL REVIEW (2015)
Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases
Ruud P. W. Litjens et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
The neurobiology of methamphetamine induced psychosis
Jennifer H. Hsieh et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2014)
Smoking Synthetic Marijuana Leads to Self-Mutilation Requiring Bilateral Amputations
Karim A. Meijer et al.
ORTHOPEDICS (2014)
Clinical differences between cocaine-induced psychotic disorder and psychotic symptoms in cocaine-dependent patients
Carlos Roncero et al.
PSYCHIATRY RESEARCH (2014)
Cannabis use and transition to psychosis in people at ultra-high risk
L. R. Valmaggia et al.
PSYCHOLOGICAL MEDICINE (2014)
Change in cannabis use in the general population: A longitudinal study on the impact on psychotic experiences
W. A. van Gastel et al.
SCHIZOPHRENIA RESEARCH (2014)
Drug Policy Governance in the UK: Lessons from changes to and debates concerning the classification of cannabis under the 1971 Misuse of Drugs Act
Mark Monaghan
INTERNATIONAL JOURNAL OF DRUG POLICY (2014)
Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series
Andreja Celofiga et al.
JOURNAL OF DUAL DIAGNOSIS (2014)
Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter
Krasnodara N. Cameron et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Psychoactive bath salts: Not so soothing
Michael H. Baumann et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Mephedrone: Public health risk, mechanisms of action, and behavioral effects
Nicholas F. Dybdal-Hargreaves et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Risk factors for cocaine-induced psychosis in cocaine-dependent patients
C. Roncero et al.
EUROPEAN PSYCHIATRY (2013)
Designer cathinones-An emerging class of novel recreational drugs
Jolanta B. Zawilska et al.
FORENSIC SCIENCE INTERNATIONAL (2013)
Association study of 37 genes related to serotonin and dopamine neurotransmission and neurotrophic factors in cocaine dependence
N. Fernandez-Castillo et al.
GENES BRAIN AND BEHAVIOR (2013)
Predictors of Persistent Psychotic Symptoms in Persons With Methamphetamine Abuse Receiving Psychiatric Treatment
Tania Lecomte et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2013)
Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans
N. R. Driesen et al.
MOLECULAR PSYCHIATRY (2013)
Psychedelics and Mental Health: A Population Study
Teri S. Krebs et al.
PLOS ONE (2013)
Synthetic Cannabinoid Overdose in a 20-Year-Old Male US Soldier
Cristobal S. Berry-Caban et al.
SUBSTANCE ABUSE (2013)
Psychotic Symptoms of Cocaine Self-Injectors in a Harm Reduction Program
Carlos Roncero et al.
SUBSTANCE ABUSE (2013)
COCAINE-INDUCED PSYCHOSIS AND IMPULSIVITY IN COCAINE-DEPENDENT PATIENTS
Carlos Roncero et al.
JOURNAL OF ADDICTIVE DISEASES (2013)
Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes
Colm M. P. O'Tuathaigh et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Synthetic Cannabinoid-Induced Psychosis: Two Adolescent Cases
Olumide O. Oluwabusi et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2012)
Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol?
Daniel Kleinloog et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Cocaine-induced psychotic symptoms in French cocaine addicts
Florence Vorspan et al.
PSYCHIATRY RESEARCH (2012)
Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort
E. Manrique-Garcia et al.
PSYCHOLOGICAL MEDICINE (2012)
Synthetic cathinones: Chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as bath salts or plant food
M. Coppola et al.
TOXICOLOGY LETTERS (2012)
Candidate pathway association study in cocaine dependence: The control of neurotransmitter release
Noelia Fernandez-Castillo et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2012)
Symptomatological Features of Patients with and without Ecstasy Use during Their First Psychotic Episode
Fabio Rugani et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2012)
Synthetic Cannabinoid Induced Psychosis in a Previously Nonpsychotic Patient
Stephanie Peglow et al.
AMERICAN JOURNAL ON ADDICTIONS (2012)
The Toxicology of Bath Salts: A Review of Synthetic Cathinones
Jane M. Prosser et al.
JOURNAL OF MEDICAL TOXICOLOGY (2012)
Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats
J. Kehr et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Synthetic cannabinoid JWH-018 and psychosis: An explorative study
Susanna Every-Palmer
DRUG AND ALCOHOL DEPENDENCE (2011)
Cathinone derivatives: A review of their chemistry, pharmacology and toxicology
John P. Kelly
DRUG TESTING AND ANALYSIS (2011)
Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service
D. James et al.
EMERGENCY MEDICINE JOURNAL (2011)
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study
Emma Barkus et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Spice: A Legal Marijuana Equivalent
Lucas A. Johnson et al.
MILITARY MEDICINE (2011)
Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency
Arne Nagels et al.
NEUROIMAGE (2011)
Disruption of Frontal Theta Coherence by Δ9-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms
Paul D. Morrison et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Psychiatric Sequelae of Spice, K2, and Synthetic Cannabinoid Receptor Agonists
Dawn M. Benford et al.
PSYCHOSOMATICS (2011)
Persistent psychosis following the use of Spice
Nancy Van Der Veer et al.
SCHIZOPHRENIA RESEARCH (2011)
Prospective Assessment of Transient Cocaine-Induced Psychotic Symptoms in a Clinical Setting
Florence Vorspan et al.
AMERICAN JOURNAL ON ADDICTIONS (2011)
Incidence of psychopathology in a cohort of young heroin and/or cocaine users
M. Jesus Herrero et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2011)
WARNING: LEGAL SYNTHETIC CANNABINOID-RECEPTOR AGONISTS SUCH AS JWH-018 MAY PRECIPITATE PSYCHOSIS IN VULNERABLE INDIVIDUALS
Susanna Every-Palmer
ADDICTION (2010)
Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias
Michael E. O'Leary et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Detection of JWH-018 metabolites in smoking mixture post-administration urine
Tim Sobolevsky et al.
FORENSIC SCIENCE INTERNATIONAL (2010)
A Teenager With Agitation Higher Than She Should Have Climbed
David Vearrier et al.
PEDIATRIC EMERGENCY CARE (2010)
The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes
Helge Mueller et al.
SCHIZOPHRENIA RESEARCH (2010)
Investigating a not-so-natural high Researchers identify synthetic cannabinoids in herbal incense
Christine Piggee
ANALYTICAL CHEMISTRY (2009)
Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol A Neural Basis for the Effects of Cannabis sativa on Learning and Psychosis
Sagnik Bhattacharyya et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
P. D. Morrison et al.
PSYCHOLOGICAL MEDICINE (2009)
First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group
Kathleen Crebbin et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2009)
Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants
James J. Mahoney et al.
AMERICAN JOURNAL ON ADDICTIONS (2008)
Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis
Carol L. M. Caton et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Comorbid psychiatric diagnoses and their association with cocaine-induced psychosis in cocaine-dependent subjects
Yi-Lang Tang et al.
AMERICAN JOURNAL ON ADDICTIONS (2007)
Human clock, PER1 and PER2 polymorphisms:: lack of association with cocaine dependence susceptibility and cocaine-induced paranoia
Robert T. Malison et al.
PSYCHIATRIC GENETICS (2006)
Risk factors for cocaine-induced paranoia in cocaine-dependent sibling pairs
Rasmon Kalayasiri et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
Risk factors for experiencing psychosis during cocaine use: A preliminary report
AG Floyd et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2006)
Rating the severity and character of transient cocaine-induced delusions and hallucinations with a new instrument, the Scale for Assessment of Positive Symptoms for Cocaine-Induced Psychosis (SAPS-CIP)
JF Cubells et al.
DRUG AND ALCOHOL DEPENDENCE (2005)
Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis
CK Chen et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
CK Chen et al.
PSYCHOLOGICAL MEDICINE (2003)
Cocaine inhibits 5-HT3 receptor function in neurons from transgenic mice overexpressing the receptor
M Carta et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients
JH Krystal et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Ecstasy-induced psychotic disorder:: Six-month follow-up study
MA Landabaso et al.
EUROPEAN ADDICTION RESEARCH (2002)
Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history
K Soar et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2001)
An exploration of the history and controversies surrounding MDMA and MDA
AR Pentney
JOURNAL OF PSYCHOACTIVE DRUGS (2001)
Long term psychiatric and cognitive effects of MDMA use
P McGuire
TOXICOLOGY LETTERS (2000)
Share Paper
